Back to search

Article

Derivation of "specific population who could benefit from Rosuvastatin": A secondary analysis on randomised controlled trial to uncover novel value of Rosuvastatin for precise treatment of ARDS

2020-06-17

Abstract excerpt

<h4>Background: </h4> The high heterogeneity of ARDS contributes to paradoxical conclusions from previous investigations of rosuvastatin for ARDS. Identification of the population (phenotype) who could benefit from rosuvastatin is a novel exploration for precise treatment of ARDS. Methods The patient population for this analysis consisted of unique patients with ARDS enrolled in the SAILS trial (Rosuvastatin vs....

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
acb004d4-37c7-5993-8c12-e722dfb2fd7c
DOI
10.21203/rs.3.rs-35420/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Derivation of "specific population who could benefit from Rosuvastatin": A secondary analysis on randomised controlled trial to uncover novel value of Rosuvastatin for precise treatment of ARDSDOI 10.21203/rs.3.rs-35420/v1
[The precision medicine for the treatment of acute respiratory distress syndrome is based on identification of phenotypes].Semantic proximity
Identification of Acute Respiratory Distress Syndrome subphenotypes denovo using routine clinical data: a retrospective analysis of ARDS clinical trialsSemantic proximity
High plasma IL-18 identifies high-risk ARDS patients not identified by latent class analysis sub-phenotyping: a secondary analysis of the SAILS and HARP-2 studiesSemantic proximity
Identification of distinct clinical phenotypes of acute respiratory distress syndrome with differential responses to treatment.Semantic proximity
Precision medicine in acute respiratory distress syndrome: workshop report and recommendations for future research.Semantic proximity
Identification and validation of distinct biological phenotypes in patients with acute respiratory distress syndrome by cluster analysis.Semantic proximity
Opportunities for improved clinical trial designs in acute respiratory distress syndrome.Semantic proximity
Acute respiratory distress syndrome subphenotypes and therapy responsive traits among preclinical models: protocol for a systematic review and meta-analysis.Semantic proximity
Use of Machine Learning to Derive Discrete Clinical Phenotypes and Assess Treatment-Effect Heterogeneity in the Steroids in Cardiac Surgery Trial Dataset.Semantic proximity
Unsupervised clustering approach to assess heterogeneity of treatment effects across patient phenotypes in randomized clinical trials.Semantic proximity
ARDS patients with CRS less than 45 cm/H2O and small body sizes may not be fit for high-PEEP levels: A secondary analysis of a randomized controlled trialSemantic proximity
Differential Effect of Positive End-Expiratory Pressure Strategies in Patients With ARDS: A Bayesian Analysis of Clinical Subphenotypes.Semantic proximity
Select a neighboring publication to make it the new centre.